CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$46.38−1.63 (-3.40%)
Close on Nov 19, 2026Market cap $1.38BP/E 19.2Yield 1.29%
Conmed net income
Net income is the profit left for shareholders after every expense, interest and tax.
Conmed's net income for the twelve months ending Sep 30, 2026 was $73.43M, up 14.6% year over year. For fiscal 2025 it was $47.06M, down 64.5% from the year before. Over ten years it grew 4.4% a year on average. The highest annual figure on record is $132.42M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.06M | -64.5% |
| FY2024 | Dec 31, 2024 | $132.42M | +105.4% |
| FY2023 | Dec 31, 2023 | $64.46M | – |
| FY2022 | Dec 31, 2022 | -$80.58M | -228.8% |
| FY2021 | Dec 31, 2021 | $62.54M | +557.2% |
| FY2020 | Dec 31, 2020 | $9.52M | -66.7% |
| FY2019 | Dec 31, 2019 | $28.62M | -29.9% |
| FY2018 | Dec 31, 2018 | $40.85M | -26.4% |
| FY2017 | Dec 31, 2017 | $55.49M | +278.4% |
| FY2016 | Dec 31, 2016 | $14.66M | -51.9% |
| FY2015 | Dec 31, 2015 | $30.50M | -5.3% |
| FY2014 | Dec 31, 2014 | $32.19M | -10.4% |
| FY2013 | Dec 31, 2013 | $35.94M | -11.2% |
| FY2012 | Dec 31, 2012 | $40.48M | +5283.1% |
| FY2011 | Dec 31, 2011 | $752.00K | -97.5% |
| FY2010 | Dec 31, 2010 | $30.35M | +150.0% |
| FY2009 | Dec 31, 2009 | $12.14M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $19.80M | +592.4% |
| Q2 FY2026 | Jun 30, 2026 | $23.07M | +7.7% |
| Q1 FY2026 | Mar 31, 2026 | $13.83M | +129.1% |
| Q4 FY2025 | Dec 31, 2025 | $16.74M | -50.4% |
| Q3 FY2025 | Sep 30, 2025 | $2.86M | -94.2% |
| Q2 FY2025 | Jun 30, 2025 | $21.42M | -28.5% |
| Q1 FY2025 | Mar 31, 2025 | $6.04M | -69.4% |
| Q4 FY2024 | Dec 31, 2024 | $33.76M | +2.1% |
| Q3 FY2024 | Sep 30, 2024 | $48.98M | +209.3% |
| Q2 FY2024 | Jun 30, 2024 | $29.98M | +118.3% |
| Q1 FY2024 | Mar 31, 2024 | $19.71M | +983.5% |
| Q4 FY2023 | Dec 31, 2023 | $33.07M | +24.4% |
| Q3 FY2023 | Sep 30, 2023 | $15.84M | -65.7% |
| Q2 FY2023 | Jun 30, 2023 | $13.73M | – |
| Q1 FY2023 | Mar 31, 2023 | $1.82M | -87.9% |
| Q4 FY2022 | Dec 31, 2022 | $26.58M | +8.8% |
| Q3 FY2022 | Sep 30, 2022 | $46.15M | +208.7% |
| Q2 FY2022 | Jun 30, 2022 | -$168.29M | -1366.3% |
| Q1 FY2022 | Mar 31, 2022 | $14.98M | +51.9% |
| Q4 FY2021 | Dec 31, 2021 | $24.44M | +1.3% |
| Q3 FY2021 | Sep 30, 2021 | $14.95M | +118.2% |
| Q2 FY2021 | Jun 30, 2021 | $13.29M | – |
| Q1 FY2021 | Mar 31, 2021 | $9.86M | +66.4% |
| Q4 FY2020 | Dec 31, 2020 | $24.14M | +61.7% |
| Q3 FY2020 | Sep 30, 2020 | $6.85M | -1.7% |
| Q2 FY2020 | Jun 30, 2020 | -$27.40M | -581.1% |
| Q1 FY2020 | Mar 31, 2020 | $5.93M | +480.5% |
| Q4 FY2019 | Dec 31, 2019 | $14.93M | -4.6% |
| Q3 FY2019 | Sep 30, 2019 | $6.97M | +19.7% |
| Q2 FY2019 | Jun 30, 2019 | $5.70M | -34.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.02M | -90.4% |
| Q4 FY2018 | Dec 31, 2018 | $15.65M | -66.5% |
| Q3 FY2018 | Sep 30, 2018 | $5.83M | -19.1% |
| Q2 FY2018 | Jun 30, 2018 | $8.72M | +42.0% |
| Q1 FY2018 | Mar 31, 2018 | $10.66M | – |
| Q4 FY2017 | Dec 31, 2017 | $46.70M | +596.1% |
| Q3 FY2017 | Sep 30, 2017 | $7.20M | – |
| Q2 FY2017 | Jun 30, 2017 | $6.14M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.55M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.71M | – |
See a number that looks wrong?